Fluorinated benzenesulfonamides as inhibitors of carbonic anhydrase
US9725467B2 · kind B2 · utility
2Cited by
0References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 30, 2012 |
| Grant date | Aug 8, 2017 |
| Priority date | — |
| Expiry date | Oct 30, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C2603/74
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Novel fluorinated benzenesulfonamides compounds of general formula (I)can be used in biomedicine as active ingredients in pharmaceutical formulations, because they inhibit enzymes which participate in disease progression.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.